conference

A CIO panel discussed why genomics IT is prepared for new security challenges and why organizations need to step up staff training and retention strategies.

Georgetown University's Subha Madhavan

Madhavan believes that the TBI community is well positioned to contribute to Precision Medicine Initiative projects both from an infrastructure and data standpoint. 

Conference attendees discussed the growing number of MALDI-TOF applications while recognizing that LDT regulation poses a particular threat to mass spec-based tests.

The conference, held at The Wellcome Trust Sanger Institute, highlighted CRISPR research from European and private sector scientists in particular.

A panel at the Bioinformatics Open Source Conference discussed ways to encourage greater diversity and deeper participation from members

NEW YORK (GenomeWeb News) – The UBS Global Life Sciences Conference wrapped up today with a handful of 'omics-related life science firms presenting to investors. Below are summaries of their pitches.
Cepheid

NEW YORK (GenomeWeb) – Wednesday marked the start of the annual UBS Global Life Sciences Conference here with a number of companies in the 'omics-related life science tools space making their pitches to investors.
Below are highlights from companies that presented yesterday.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – The UBS Global Life Sciences Conference concluded on Wednesday with presentations in the afternoon by GenturaDx and Epigenomics.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Wednesday marked the last day of the UBS Global Life Sciences Conference where Affymetrix and Exiqon presented to investors.
Below are highlights from their talks.

Pages

The ancestors of the Arizona bark scorpion and other scorpions and spiders underwent whole-genome duplication, KJZZ reports.

A cryptographic approach could help researchers keep genomic data private while researchers analyze it, Scientific American reports.

Andy Page, the former president of 23andMe, has joined a diabetes-management startup, according to CNBC.

In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.